Kairos Pharma Ltd KAPA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Stage Continues Theravance Biopharma Inc TBPH Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Surprise Workhorse Group Q1 2026 Earnings EPS Miss Widens as Company Remains PreRevenue CDIO Q1 2025 Earnings Narrowed Loss Beats Estimates Significantly Redhill Biopharma RDHL Q2 2022 Earnings Massive EPS Miss Raises Liquidity Concerns EQR Q1 2026 Earnings EPS Falls Short of Estimates by 257 AVX Q1 2026 Earnings Narrowing Loss in Core Operations Amid Quiet Quarter Billionaire Stanley Druckenmiller Invests 3387 Million in Caris Life Sciences During Q1 ZVRA Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response MTH Q1 2026 Earnings EPS Misses Estimates Stock Inches Higher MMYT Q1 2026 Earnings EPS Misses Estimates Amid Strong Travel Demand Stock Edges Up NCTY Q1 2012 Earnings NarrowerthanExpected Loss as ADR Edges Higher MDA Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction